Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DYM antisense RNA 1 (DYM-AS1) is a long non-coding RNA (lncRNA) named as the antisense transcript to the gene DYM. Long non-coding RNAs are a class of RNA molecules greater than 200 nucleotides in length that do not code for a protein but may have regulatory roles at the transcriptional, post-transcriptional, or epigenetic level. The specific biological function of DYM-AS1 is not well described in public biomedical literature or databases, and it is not recognized as a validated therapeutic or diagnostic target. As of now, DYM-AS1 is primarily of research interest and not clinically actionable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DYM antisense RNA 1 (DYM-AS1).